Vilon
Vilon reaches for the same broad target as Thymosin Alpha-1 — immune function in aging — through an entirely different, and more speculative, route: it's the shortest peptide in the Khavinson bioregulator family.
Not currently stocked by KYIN Peptides, but available to order — see availability below.
What Is Vilon?
Vilon is the shortest peptide in the Khavinson bioregulator family — a two-amino-acid dipeptide (Lys-Glu) — proposed to bind DNA in thymic tissue and influence gene expression governing T-cell maturation. Like other bioregulator peptides in this lineage, it works by a proposed direct chromatin-binding mechanism rather than a conventional cell-surface receptor pathway.
Research Focus
Vilon is relevant to general immune function and health in aging rather than localized tissue repair, distinguishing it from the gastric-, actin-, and copper-based repair pathways studied for compounds like BPC-157 and TB-500. It shares its broad research target — immune modulation — with Thymosin Alpha-1, though the two compounds reach for it through very different mechanisms and very different levels of evidence. See our Healing & Recovery research overview for how it fits alongside KYIN's stocked recovery-focused peptides.
Clinical & Preclinical Trial Data
The core evidence for Vilon is a single, decades-old animal lifespan study (Khavinson & Anisimov, Doklady Biological Sciences): chronic Vilon administration in female CBA mice — a strain predisposed to spontaneous mammary tumors — extended lifespan by 20–40% and reduced the incidence of spontaneous lung adenomas, without significantly changing body weight or food consumption. This has not been independently replicated outside Khavinson-affiliated Russian research, and no human trial of Vilon has been conducted.
Availability
Vilon is not part of KYIN Peptides' standard catalogue, but it is available to order — contact us directly and we'll source it for you.
Vilon questions
What is Vilon?
Vilon is the shortest peptide in the Khavinson bioregulator family — a two-amino-acid dipeptide (Lys-Glu) — proposed to bind DNA in thymic tissue and influence gene expression governing T-cell maturation, targeting immune function in aging.
What evidence exists for Vilon?
The core evidence is a single, decades-old animal lifespan study (Khavinson & Anisimov): chronic Vilon administration in female CBA mice extended lifespan by 20–40% and reduced the incidence of spontaneous lung adenomas. This has not been independently replicated outside Khavinson-affiliated Russian research, and no human trial of Vilon has been conducted.
Does KYIN Peptides sell Vilon?
Not as part of our standard catalogue, but yes — it's available to order. Contact us directly and we'll source it for you.
Interested in sourcing Vilon?
Contact us and we'll help you source it, or browse our stocked recovery-focused peptides.